Artal Group S.A. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 68 filers reported holding OVID THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,923,000
-74.8%
2,500,0000.0%0.05%
-74.7%
Q1 2024$7,625,000
+94620.5%
2,500,0000.0%0.19%
-27.6%
Q4 2023$8,050
-16.1%
2,500,0000.0%0.27%
-35.0%
Q3 2023$9,600
+17.1%
2,500,0000.0%0.41%
+62.2%
Q2 2023$8,200
+27.1%
2,500,0000.0%0.25%
-33.7%
Q1 2023$6,450
+38.7%
2,500,0000.0%0.38%
+47.3%
Q4 2022$4,650
-99.9%
2,500,0000.0%0.26%
+32.7%
Q3 2022$4,600,000
-14.4%
2,500,0000.0%0.20%
-31.7%
Q2 2022$5,375,000
-31.5%
2,500,0000.0%0.29%
-12.8%
Q1 2022$7,850,000
-2.2%
2,500,0000.0%0.33%
+50.9%
Q4 2021$8,025,000
-4.5%
2,500,0000.0%0.22%
+16.0%
Q3 2021$8,400,000
-14.1%
2,500,0000.0%0.19%
-5.1%
Q2 2021$9,775,000
-2.7%
2,500,0000.0%0.20%
+11.2%
Q1 2021$10,050,000
+74.0%
2,500,0000.0%0.18%
+43.5%
Q4 2020$5,775,000
-59.8%
2,500,0000.0%0.12%
-64.4%
Q3 2020$14,350,0002,500,0000.35%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,540,671$2,835,0001.27%
Madison Avenue Partners, LP 1,394,022$2,565,0000.55%
BVF INC/IL 6,851,051$12,606,0000.52%
CHI Advisors LLC 864,822$1,591,0000.43%
Rubric Capital Management LP 4,516,300$8,310,0000.42%
EcoR1 Capital, LLC 6,117,400$11,256,0000.33%
Artal Group S.A. 2,500,000$4,600,0000.20%
DCF Advisers, LLC 162,701$299,0000.19%
Oasis Management Co Ltd. 270,000$497,0000.08%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 908,500$1,672,0000.04%
View complete list of OVID THERAPEUTICS INC shareholders